EP Patent

EP4545122A2 — DEVICE, METHODS AND USES FOR THE TREATMENT OF ANAPHYLAXIS

Assigned to Kokua Pharma Inc · Expires 2025-04-30 · 1y expired

What this patent protects

The present disclosure provides a metered dose inhaler (MDI) comprising an API formulation suitable for administration to a patient in need thereof by inhalation, as well as methods and uses of the MDI.

USPTO Abstract

The present disclosure provides a metered dose inhaler (MDI) comprising an API formulation suitable for administration to a patient in need thereof by inhalation, as well as methods and uses of the MDI.

Drugs covered by this patent

Patent Metadata

Patent number
EP4545122A2
Jurisdiction
EP
Classification
—
Expires
2025-04-30
Drug substance claim
No
Drug product claim
No
Assignee
Kokua Pharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.